-
1دورية أكاديمية
المؤلفون: Yoshiya Tanaka, Tsutomu Takeuchi, Tatsuya Atsumi, Bernard G. Combe, Daniel Aletaha, Toshihiko Kaise, Vijay Rajendran
المصدر: Rheumatology and Therapy, Vol 10, Iss 6, Pp 1399-1415 (2023)
مصطلحات موضوعية: Filgotinib, Poor prognostic factors, Adalimumab, Methotrexate, Rheumatoid arthritis, Diseases of the musculoskeletal system, RC925-935
وصف الملف: electronic resource
-
2دورية أكاديمية
المصدر: Онкогематология, Vol 0, Iss 3, Pp 18-24 (2022)
مصطلحات موضوعية: anaplastic large-cell lymphoma, poor prognostic factors, long-term results of therapy, Diseases of the blood and blood-forming organs, RC633-647.5
وصف الملف: electronic resource
العلاقة: https://oncohematology.abvpress.ru/ongm/article/view/720Test; https://doaj.org/toc/1818-8346Test; https://doaj.org/toc/2413-4023Test
-
3دورية أكاديمية
المؤلفون: Bernard G. Combe, Yoshiya Tanaka, Maya H. Buch, Peter Nash, Gerd R. Burmester, Alan J. Kivitz, Beatrix Bartok, Alena Pechonkina, Katrina Xia, Kahaku Emoto, Shungo Kano, Thijs K. Hendrikx, Robert B. M. Landewé, Daniel Aletaha
المصدر: Rheumatology and Therapy, Vol 10, Iss 1, Pp 53-70 (2022)
مصطلحات موضوعية: Filgotinib, Poor prognostic factors, Adalimumab, Methotrexate, Diseases of the musculoskeletal system, RC925-935
وصف الملف: electronic resource
-
4دورية أكاديمية
المؤلفون: A. N. Polyakov, D. A. Granov, Yu. I. Patyutko, I. A. Pokataev, A. A. Polikarpov, T. I. Kagacheva, I. S. Bazin, A. Sh. Umirzokov, D. Yu. Frantsev, V. N. Zhuikov, D. V. Podluzhny, А. Н. Поляков, Д. А. Гранов, Ю. И. Патютко, И. A. Покатаев, А. А. Поликарпов, Т. И. Кагачева, И. С. Базин, А. Ш. Умирзоков, Д. Ю. Францев, В. Н. Жуйков, Д. В. Подлужный
المصدر: Research and Practical Medicine Journal; Том 10, № 1 (2023); 57-67 ; Research'n Practical Medicine Journal; Том 10, № 1 (2023); 57-67 ; 2410-1893 ; 10.17709/2410-1893-2023-10-1
مصطلحات موضوعية: факторы неблагоприятного прогноза, combination therapy, preoperative chemotherapy, transarterial chemoembolization, hepatic artery infusion chemotherapy, post‑resection liver failure, poor prognostic factors, комбинированное лечение, предоперационная химиотерапия, химиоэмболизация печеночной артерии, химиоинфузия печеночной артерии, пострезекционная печеночная недостаточность
وصف الملف: application/pdf
العلاقة: https://www.rpmj.ru/rpmj/article/view/860/538Test; https://www.rpmj.ru/rpmj/article/view/860/546Test; https://www.rpmj.ru/rpmj/article/downloadSuppFile/860/707Test; https://www.rpmj.ru/rpmj/article/downloadSuppFile/860/708Test; https://www.rpmj.ru/rpmj/article/downloadSuppFile/860/709Test; https://www.rpmj.ru/rpmj/article/downloadSuppFile/860/710Test; https://www.rpmj.ru/rpmj/article/downloadSuppFile/860/711Test; Primrose JN, Fox RP, Palmer DH, Malik HZ, Prasad R, Mirza D, et al.; BILCAP study group. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019 May;20(5):663–673. https://doi.org/10.1016/s1470Test‑2045(18)30915‑x Erratum in: Lancet Oncol. 2019 Apr 2.; Yadav S, Xie H, Bin‑Riaz I, Sharma P, Durani U, Goyal G, et al. Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: propensity score matched analysis. Eur J Surg Oncol. 2019 Aug;45(8):1432–1438. https://doi.org/10.1016/j.ejso.2019.03.023Test; Tsilimigras DI, Sahara K, Wu L, Moris D, Bagante F, Guglielmi A, et al. Very Early Recurrence After Liver Resection for Intrahepatic Cholangiocarcinoma: Considering Alternative Treatment Approaches. JAMA Surg. 2020 Sep 1;155(9):823–831. https://doi.org/10.1001/jamasurg.2020.1973Test; Rizzo A, Brandi G. Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review. Cancer Treat Res Commun. 2021;27:100354. https://doi.org/10.1016/j.ctarc.2021.100354Test; Zhang XF, Beal EW, Bagante F, Chakedis J, Weiss M, Popescu I, et al. Early versus late recurrence of intrahepatic cholangiocarcinoma after resection with curative intent. Br J Surg. 2018 Jun;105(7):848–856. https://doi.org/10.1002/bjs.10676Test; Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A, et al.; ABC‑02 Trial Investigators. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med. 2010 Apr 8;362(14):1273–1281. https://doi.org/10.1056/nejmoa0908721Test; Rizzo A, Brandi G. First‑line Chemotherapy in Advanced Biliary Tract Cancer Ten Years After the ABC‑02 Trial: “And Yet It Moves!”. Cancer Treat Res Commun. 2021;27:100335. https://doi.org/10.1016/j.ctarc.2021.100335Test; Cho Y, Kim TH, Seong J. Improved oncologic outcome with chemoradiotherapy followed by surgery in unresectable intrahepatic cholangiocarcinoma. Strahlenther Onkol. 2017 Aug;193(8):620–629. https://doi.org/10.1007/s00066Test‑017‑1128‑7; Kato A, Shimizu H, Ohtsuka M, Yoshidome H, Yoshitomi H, Furukawa K, et al. Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single‑center study. Ann Surg Oncol. 2013 Jan;20(1):318–324. https://doi.org/10.1245/s10434Test‑012‑2312‑8; Shroff RT, Javle MM, Xiao L, Kaseb AO, Varadhachary GR, Wolff RA, et al. Gemcitabine, Cisplatin, and nab‑Paclitaxel for the Treatment of Advanced Biliary Tract Cancers: A Phase 2 Clinical Trial. JAMA Oncol. 2019 Jun 1;5(6):824–830. https://doi.org/10.1001/jamaoncol.2019.0270Test; Ray CE Jr, Edwards A, Smith MT, Leong S, Kondo K, Gipson M, et al. Metaanalysis of survival, complications, and imaging response following chemotherapy‑based transarterial therapy in patients with unresectable intrahepatic cholangiocarcinoma. J Vasc Interv Radiol. 2013 Aug;24(8):1218–1226. https://doi.org/10.1016/j.jvir.2013.03.019Test; Holster JJ, El Hassnaoui M, Franssen S, IJzermans JNM, de Jonge J, Mostert B, et al. Hepatic Arterial Infusion Pump Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta‑Analysis. Ann Surg Oncol. 2022 Sep;29(9):5528–5538. https://doi.org/10.1245/s10434Test‑022‑11439‑x; https://www.rpmj.ru/rpmj/article/view/860Test
الإتاحة: https://doi.org/10.17709/2410-1893-2023-10-1-5Test
https://doi.org/10.17709/2410-1893-2023-10-1Test
https://doi.org/10.1016/s1470Test‑2045(18)30915‑x
https://doi.org/10.1016/j.ejso.2019.03.023Test
https://doi.org/10.1001/jamasurg.2020.1973Test
https://doi.org/10.1016/j.ctarc.2021.100354Test
https://doi.org/10.1002/bjs.10676Test
https://doi.org/10.1056/nejmoa0908721Test
https://doi.org/10.1016/j.ctarc.2021.100335Test
https://doi.org/10.1007/s00066Test‑017‑1128‑7 -
5دورية أكاديمية
المؤلفون: Ai Matsui, Akifumi Suzuki, Chie Masaki, Chisato Tomoda, Hiroshi Takami, Junko Akaishi, Kana Yoshioka, Kenichi Matsuzu, Kiminori Sugino, Kiyomi Hames, Koichi Ito, Mitsuji Nagahama, Ritsuko Okamura, Wataru Kitagawa, Yoko Kuga, Yoshiyuki Saito, ヘイムス 規予美, 伊藤 公一, 北川 亘, 友田 智哲, 吉岡 佳奈, 岡村 律子, 斎藤 慶幸, 杉野 公則, 松井 愛唯, 松津 賢一, 正木 千恵, 空閑 陽子, 赤石 純子, 鈴木 章史, 長濱 充二, 高見 博
المصدر: 日本内分泌外科学会雑誌 / Official Journal of the Japan Association of Endocrine Surgery. 2023, 40(3):145
-
6دورية أكاديمية
المؤلفون: Combe, Bernard G, Tanaka, Yoshiya, Buch, Maya H, Nash, Peter, Burmester, Gerd R, Kivitz, Alan J, Bartok, Beatrix, Pechonkina, Alena, Xia, Katrina, Emoto, Kahaku, Kano, Shungo, Hendrikx, Thijs K, Landewe, Robert BM, Aletaha, Daniel
مصطلحات موضوعية: Immunology, Pharmacology and pharmaceutical sciences, Science & Technology, Life Sciences & Biomedicine, Rheumatology, Filgotinib, Poor prognostic factors
العلاقة: Rheumatology and Therapy; Combe, BG; Tanaka, Y; Buch, MH; Nash, P; Burmester, GR; Kivitz, AJ; Bartok, B; Pechonkina, A; Xia, K; Emoto, K; Kano, S; Hendrikx, TK; Landewe, RBM; Aletaha, D, Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study, Rheumatology and Therapy, 2022; http://hdl.handle.net/10072/419057Test
-
7دورية أكاديمية
المؤلفون: Daniel Aletaha, René Westhovens, Cecile Gaujoux-Viala, Giovanni Adami, Alan Matsumoto, Paul Bird, Osvaldo Daniel Messina, Maya H Buch, Beatrix Bartok, Zhaoyu Yin, Ying Guo, Thijs Hendrikx, Gerd R Burmester
المساهمون: Aletaha, Daniel, Westhovens, René, Gaujoux-Viala, Cecile, Adami, Giovanni, Matsumoto, Alan, Bird, Paul, Daniel Messina, Osvaldo, H Buch, Maya, Bartok, Beatrix, Yin, Zhaoyu, Guo, Ying, Hendrikx, Thij, R Burmester, Gerd
مصطلحات موضوعية: Poor prognostic factors, Rheumatoid arthritis, Filgotinib
العلاقة: volume:7; issue:2; firstpage:e001621; lastpage:e001621; numberofpages:18; journal:RMD OPEN; http://hdl.handle.net/11562/1047239Test
-
8
المؤلفون: Somkrit Sripontan
المصدر: Asian Journal of Neurosurgery
مصطلحات موضوعية: Vital signs, Case Report, 030218 nuclear medicine & medical imaging, law.invention, Lesion, 03 medical and health sciences, 0302 clinical medicine, Hematoma, Modified Rankin Scale, law, medicine, Intracranial pressure, massive pontine hemorrhage, hypertensive hemorrhage, business.industry, Glasgow Coma Scale, General Medicine, medicine.disease, Intensive care unit, Good recovery, Blood pressure, Anesthesia, medicine.symptom, poor prognostic factors, business, 030217 neurology & neurosurgery
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28f0075b992b4ed53244212537986352Test
http://europepmc.org/articles/PMC6703036Test -
9
المؤلفون: Z. Yin, Cécile Gaujoux-Viala, Gerd R Burmester, Alan Matsumoto, Ying Guo, Rene Westhovens, Thijs Hendrikx, Giovanni Adami, Beatrix Bartok, Osvaldo D. Messina, Paul Bird, Maya H Buch, Daniel Aletaha
المصدر: RMD Open
RMD Open, Vol 7, Iss 2 (2021)
Aletaha, D, Westhovens, R, Gaujoux-viala, C, Adami, G, Matsumoto, A, Bird, P, Messina, O D, Buch, M H, Bartok, B, Yin, Z, Guo, Y, Hendrikx, T & Burmester, G R 2021, ' Efficacy and safety of filgotinib in methotrexate-naive patients with rheumatoid arthritis with poor prognostic factors: post hoc analysis of FINCH 3 ', RMD Open, vol. 7, no. 2, pp. e001621 . https://doi.org/10.1136/rmdopen-2021-001621Testمصطلحات موضوعية: antirheumatic agents, Pyridines, PREDICTION, Arthritis, Gastroenterology, Arthritis, Rheumatoid, immune system diseases, therapeutics, Immunology and Allergy, skin and connective tissue diseases, education.field_of_study, biology, Prognosis, Poor prognostic factors, Treatment Outcome, JAK1, arthritis, Rheumatoid arthritis, RISK MODEL, Medicine, Drug Therapy, Combination, Life Sciences & Biomedicine, musculoskeletal diseases, medicine.medical_specialty, Filgotinib, rheumatoid, Immunology, Population, Rheumatoid Arthritis, GLPG0634/GS-6034, AMERICAN-COLLEGE, Rheumatology, RAPID RADIOGRAPHIC PROGRESSION, Internal medicine, Post-hoc analysis, medicine, Humans, Rheumatoid factor, education, Science & Technology, business.industry, C-reactive protein, SELECTIVE INHIBITOR, Triazoles, medicine.disease, Methotrexate, DEFINITION, biology.protein, business
وصف الملف: Print; application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1eee3da5c24608265d872345f1c51587Test
https://lirias.kuleuven.be/handle/123456789/682662Test -
10
المؤلفون: Baganz, Lisa
مصطلحات موضوعية: rheumatoid arthritis, tocilizumab, treatment strategies, observational data, psoriasis, poor prognostic factors, 600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bc8936011e5db0b3e5a0e4e2dab7606Test